Burges Salmon has advised PlaqueTec Limited. PlaqueTec Limited, a Cambridge-based medtech company specializing in intracoronary liquid biopsy technologies, has completed a $5 million oversubscribed investment fundraise….
PlaqueTec Raises $5 Million in Oversubscribed Investment Round

























